Valdenassi L - Search Results

1

The need for a correct oxygen-ozone autohemotherapy (O₃-AHT) in patients with mild to moderate COVID-19 pneumonia.

Chirumbolo S, Pandolfi S, Valdenassi L, Bertossi D, Franzini M. Chirumbolo S, et al. Among authors: valdenassi l. Intern Emerg Med. 2021 Apr;16(3):793-794. doi: 10.1007/s11739-020-02592-w. Epub 2021 Jan 5. Intern Emerg Med. 2021. PMID: 33400161 Free PMC article. No abstract available.

2

Ozone autohemotherapy induces long-term cerebral metabolic changes in multiple sclerosis patients.

Molinari F, Simonetti V, Franzini M, Pandolfi S, Vaiano F, Valdenassi L, Liboni W. Molinari F, et al. Among authors: valdenassi l. Int J Immunopathol Pharmacol. 2014 Jul-Sep;27(3):379-89. doi: 10.1177/039463201402700308. Int J Immunopathol Pharmacol. 2014. PMID: 25280029 Free article.

3

Cerebrovascular pattern improved by ozone autohemotherapy: an entropy-based study on multiple sclerosis patients.

Molinari F, Rimini D, Liboni W, Acharya UR, Franzini M, Pandolfi S, Ricevuti G, Vaiano F, Valdenassi L, Simonetti V. Molinari F, et al. Among authors: valdenassi l. Med Biol Eng Comput. 2017 Aug;55(8):1163-1175. doi: 10.1007/s11517-016-1580-z. Epub 2016 Oct 12. Med Biol Eng Comput. 2017. PMID: 27734309

4

Ozone Exerts Cytoprotective and Anti-Inflammatory Effects in Cardiomyocytes and Skin Fibroblasts after Incubation with Doxorubicin.

Simonetti V, Quagliariello V, Franzini M, Iaffaioli RV, Maurea N, Valdenassi L. Simonetti V, et al. Among authors: valdenassi l. Evid Based Complement Alternat Med. 2019 Nov 18;2019:2169103. doi: 10.1155/2019/2169103. eCollection 2019. Evid Based Complement Alternat Med. 2019. PMID: 31827546 Free PMC article.

5

Potential mechanisms by which the oxygen-ozone (O2-O3) therapy could contribute to the treatment against the coronavirus COVID-19.

Valdenassi L, Franzini M, Ricevuti G, Rinaldi L, Galoforo AC, Tirelli U. Valdenassi L, et al. Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4059-4061. doi: 10.26355/eurrev_202004_20976. Eur Rev Med Pharmacol Sci. 2020. PMID: 32374009 Free article. No abstract available.

6

Oxygen-ozone (O₂-O₃) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported.

Franzini M, Valdenassi L, Ricevuti G, Chirumbolo S, Depfenhart M, Bertossi D, Tirelli U. Franzini M, et al. Among authors: valdenassi l. Int Immunopharmacol. 2020 Nov;88:106879. doi: 10.1016/j.intimp.2020.106879. Epub 2020 Aug 8. Int Immunopharmacol. 2020. PMID: 32795898 Free PMC article.

7

Oxygen-ozone autohemotherapy against COVID-19 needs to fit highly experienced, customized, and standardized protocols to succeed.

Chirumbolo S, Franzini M, Simonetti V, Valdenassi L, Ricevuti G, Bertossi D, Pandolfi S. Chirumbolo S, et al. Among authors: valdenassi l. J Med Virol. 2021 May;93(5):2580-2582. doi: 10.1002/jmv.26806. Epub 2021 Jan 27. J Med Virol. 2021. PMID: 33503267 Free PMC article. No abstract available.

8

Estimating coronavirus disease 2019 (COVID-19)-caused deaths in hospitals and healthcare units: Do hospital-acquired infections play a role? Comments with a proposal.

Chirumbolo S, Simonetti V, Franzini M, Valdenassi L, Bertossi D, Pandolfi S. Chirumbolo S, et al. Among authors: valdenassi l. Infect Control Hosp Epidemiol. 2022 Jun;43(6):810-811. doi: 10.1017/ice.2021.122. Epub 2021 Mar 19. Infect Control Hosp Epidemiol. 2022. PMID: 33736720 Free PMC article. No abstract available.

9

Insights on the mechanisms of action of ozone in the medical therapy against COVID-19.

Chirumbolo S, Valdenassi L, Simonetti V, Bertossi D, Ricevuti G, Franzini M, Pandolfi S. Chirumbolo S, et al. Among authors: valdenassi l. Int Immunopharmacol. 2021 Jul;96:107777. doi: 10.1016/j.intimp.2021.107777. Epub 2021 May 11. Int Immunopharmacol. 2021. PMID: 34020394 Free PMC article. Review.

10

Fatigue in post-acute sequelae of SARS-CoV2 (PASC) treated with oxygen-ozone autohemotherapy - preliminary results on 100 patients.

Tirelli U, Franzini M, Valdenassi L, Pisconti S, Taibi R, Torrisi C, Pandolfi S, Chirumbolo S. Tirelli U, et al. Among authors: valdenassi l. Eur Rev Med Pharmacol Sci. 2021 Sep;25(18):5871-5875. doi: 10.26355/eurrev_202109_26809. Eur Rev Med Pharmacol Sci. 2021. PMID: 34604980 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters